Health
Persistent immune thrombocytopaenic purpura associated with SARS‐CoV‐2 infection – Wiley
Click on the article title to read more.
We describe evolution of persistent immune thrombocytopaenic purpura (ITP) from acute ITP in a young woman with clinically otherwise inapparent severe acute respiratory syndrome coronavirus 2 (SARSCoV2) infection (COVID19); her development of ITP was matter for an earlier report.[1] ITP is an acquired disease in which thrombocytopaenia results from autoantibodies against platelet antigens. Approximately 10% of patients with acute ITP develop persistent (lasting 312 months) or chronic (>12 months)…
-
Noosa News18 hours agoHelicopter pilots saving lives, providing food and fodder in flooded outback Queensland
-
Noosa News22 hours ago’Lethal new opioids’ prompt Wide Bay pill testing call
-
General17 hours agoInternal Revenue Service starts cutting 20,000 workers
-
Noosa News17 hours agoMan killed, woman seriously injured in collision in Wongabel, Atherton Tablelands, Queensland